A detailed history of Capital Investment Counsel, Inc transactions in Eli Lilly & CO stock. As of the latest transaction made, Capital Investment Counsel, Inc holds 745 shares of LLY stock, worth $555,919. This represents 0.1% of its overall portfolio holdings.

Number of Shares
745
Previous 745 -0.0%
Holding current value
$555,919
Previous $674,000 2.08%
% of portfolio
0.1%
Previous 0.1%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 22, 2024

BUY
$724.87 - $909.04 $102,931 - $129,083
142 Added 23.55%
745 $674,000
Q4 2023

Feb 05, 2024

BUY
$525.19 - $619.13 $54,094 - $63,770
103 Added 20.6%
603 $351,000
Q2 2023

Jul 28, 2023

BUY
$350.74 - $468.98 $175,370 - $234,490
500 New
500 $234,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $709B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Capital Investment Counsel, Inc Portfolio

Follow Capital Investment Counsel, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Investment Counsel, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Capital Investment Counsel, Inc with notifications on news.